Pre-Injection Preparation Wash your hands well with soap and water
Most people find the injections to be very manageable
FDA prescribing information, Mounjaro (tirzepatide) injection, BLA 215866: approved indications, once-weekly 2.515 mg titration, ~5-day half-life, boxed warning for thyroid C-cell tumors
This compounded preparation: Has not been approved by the FDA Has not undergone FDA review for safety, effectiveness, or quality Is prepared specifically for you based on your prescriber's order Individual outcomes may vary Dosing is determined by the prescribing provider based on patient-specific factors
These are general physiological roles of glutathione not promises of medical treatment
TPE is performed under the care of a licensed medical provider and monitored by healthcare professionals